HeartSciences Inc.
HSCS
$3.75
$0.3710.95%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.20% | 30.45% | -3.55% | 11.20% | -21.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.39% | 53.98% | 26.13% | 55.99% | 17.58% |
| Operating Income | -2.16% | -55.47% | -26.44% | -55.99% | -17.58% |
| Income Before Tax | -13.44% | -54.29% | -19.13% | -50.10% | -13.10% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.44% | -54.29% | -19.13% | -50.10% | -13.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.44% | -54.29% | -19.13% | -50.10% | -13.10% |
| EBIT | -2.16% | -55.47% | -26.44% | -55.99% | -17.58% |
| EBITDA | -2.26% | -55.45% | -26.28% | -55.96% | -17.51% |
| EPS Basic | 30.86% | 14.46% | 85.74% | 80.06% | 83.21% |
| Normalized Basic EPS | 30.87% | 14.46% | 85.74% | 80.06% | 83.21% |
| EPS Diluted | 30.86% | 14.46% | 85.74% | 80.06% | 83.21% |
| Normalized Diluted EPS | 30.87% | 14.46% | 85.74% | 80.06% | 83.21% |
| Average Basic Shares Outstanding | 64.10% | 80.37% | 735.52% | 652.86% | 573.48% |
| Average Diluted Shares Outstanding | 64.10% | 80.37% | 735.52% | 652.86% | 573.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |